Women's Health
|
March 28, 2025

Chlamydia and Pregnancy: Every Expectant Mother Should Know

Medically Reviewed by
Updated On
April 1, 2025

Chlamydia is the most frequently reported bacterial infection in the United States, affecting nearly 1 in 20 women of reproductive age. Though it often doesn't show symptoms, chlamydia can cause potential complications for mother and baby if left untreated during pregnancy, which is why the Centers for Disease Control and Prevention (CDC) recommends that pregnant women be screened for chlamydia at their first prenatal appointment.

[signup]

Understanding Chlamydia

Chlamydia is a preventable and treatable sexually transmitted infection (STI) that can affect men and women. It is a bacterial infection caused by Chlamydia trachomatis that can be transmitted from person to person via vaginal, anal, or oral sex. It can also be passed from an infected mother to her child during childbirth. 

Prevalence

According to the World Health Organization (WHO), the global prevalence of chlamydia among people ages 15-49 years was estimated to be 4% for women and 2.5% for men in 2020. In that same year, there were an estimated 128.5 million newly diagnosed chlamydial infections worldwide among adults. 

In the United States, chlamydia is more common in women than in men. It affects women at twice the rate of men, with the highest prevalence among young people, particularly women ages 15-24 and men ages 20-24.

Other populations at higher risk for chlamydia include:

  • Men who have sex with men
  • Black and non-Hispanic populations

Symptoms

Most people with chlamydia are asymptomatic. If symptoms do appear, they may present weeks after exposure to the infection. 

Symptoms in Women

In females, chlamydia infects the cervix most frequently. This can cause:

  • Abnormal vaginal discharge
  • Vaginal bleeding
  • Pain during urination

Symptoms in Men

If symptoms occur in men, they may include:

  • Penile discharge
  • Itching
  • Pain during urination

Rectal Symptoms

Infections can occur in the rectum by having anal sex or by being spread from another location. If symptoms occur, they may include rectal pain, bleeding, and discharge.

Complications

Even if chlamydia doesn't cause acute symptoms, it may increase the risk of health complications in men and women. 

  • In women, untreated chlamydia can increase the risk of pelvic inflammatory disease (PID), ectopic pregnancy, infertility, and chronic pelvic pain. 
  • In men, untreated chlamydia can lead to epididymitis and reduced fertility. 
  • If Chlamydia trachomatis travels into the bloodstream, it can cause reactive arthritis and increase the risk of acquiring human immunodeficiency virus (HIV). 

Chlamydia During Pregnancy

Pregnancy does not protect against chlamydia. 

Untreated chlamydia infections during pregnancy increase the risk of pregnancy complications:

  • Pre-term delivery
  • Low birth weight 
  • Postpartum infections, including endometritis (inflammation of the uterus's inner lining)

An infected mother can also transmit chlamydia to her baby during childbirth. Babies who are born with chlamydia can develop: 

  • Chlamydial conjunctivitis (18-44% of cases): an eye infection that presents with redness, swelling, and discharge
  • Chlamydial pneumonia (3-16% of cases): an afebrile lung infection that presents with rapid breathing and a cough

Diagnosis and Screening

Early diagnosis and treatment of chlamydia can prevent the infection from causing irreversible damage to the mother's reproductive tract and neonatal transmission

According to the U.S. Preventive Services Task Force (USPSTF), screening and treatment of chlamydial infection during pregnancy is associated with improved outcomes for infants and mothers, including significantly lower rates of preterm delivery, early rupture of membranes, and low birth weight infants.

Screening Guidelines

The CDC recommends annual screening for chlamydia in the following groups:

  • Sexually active women under the age of 25
  • Sexually active women older than 25 who are at an increased risk for infection. Risk factors include having a new sex partner, multiple sex partners, a sex partner with concurrent partners, or a sex partner who has an STI.
  • Men who have sex with men
  • People with HIV

For pregnant women, the CDC advises routine screening for those under 25 years of age and for older pregnant women at increased risk at the first prenatal visit. Pregnant women who remain at risk should be retested during the third trimester to prevent maternal and neonatal complications.

Diagnostic Testing

Due to its high sensitivity and specificity, nucleic amplification testing (NAAT) is the gold standard for diagnosing urogenital chlamydia. 

NAATs can be performed on various clinical specimens. The preferred specimens are: 

  • Vaginal swabs for women
  • First-catch urine for men
  • Rectal swabs to screen for rectal infections in people who engage in anal sex 

If chlamydia is detected and treated during the first trimester of pregnancy, repeat testing for reinfection should be performed within 3-6 months or during the third trimester of pregnancy.

Patients diagnosed with chlamydia should also be tested for the following co-infections:

  • HIV
  • Gonorrhea
  • Syphilis

Treatment Options

Antibiotic treatment should be initiated immediately upon diagnosing chlamydia to prevent infection-related complications. 

Antibiotics

Antibiotic treatment options for pregnant women include: 

  • Azithromycin 1 gram orally in a single dose
  • Amoxicillin 500 mg orally three times daily for seven days
  • Erythromycin 500 mg four times daily for seven days or 250 mg four times daily for 14 days

According to a meta-analysis, while all three medications have a similar efficacy rate, azithromycin may be associated with the lowest risk of side effects. 

Doxycycline, commonly used to treat chlamydia in non-pregnant individuals, is contraindicated during pregnancy and breastfeeding due to its potential to affect fetal bone and tooth development, as well as the risk of discoloration of teeth in infants and young children.

Integrative Approaches

People undergoing chlamydia treatment should abstain from sexual activity until they and their partners have completed treatment and are asymptomatic. 

  • If prescribed a single dose of medication, wait at least seven days before having sex. 
  • If prescribed a multi-day course of antibiotics, wait until the entire course of treatment is completed before resuming sexual activity.

Sexual partners should also be referred for evaluation, diagnosis, and treatment if:

  • They had sexual contact with the patient within 60 days of symptom onset or diagnosis.
  • If the last sexual contact was more than 60 days before symptom onset or diagnosis, the most recent partner should be evaluated.

Prevention Strategies

The only way to completely prevent chlamydia is to abstain from vaginal, oral, and anal sex. 

Sexually active individuals can reduce their risk of getting chlamydia by:

  • Using condoms during vaginal, oral, and anal sex
  • Using dental dams during oral sex
  • Not sharing sex toys
  • Being in a mutually monogamous sexual relationship with a partner who does not have chlamydia

Living with Chlamydia During Pregnancy

Receiving an STI diagnosis can have a significant psychological impact, leading to feelings of shock, shame, anxiety, and depression. Healthcare initiatives that promote sexual education and open communication can help destigmatize and alleviate fears associated with the diagnosis. 

The USPSTF recommends referring all patients with current or recent STIs to high-intensity behavioral counseling.

Connecting with other expectant mothers who have similar experiences can provide emotional and social support to reduce feelings of isolation.

After treatment, regular follow-up visits are important to monitor the patient's health and ensure the infection has been fully cleared. Follow-up testing may be recommended for the woman and her baby, especially if complications arise during or after pregnancy.

[signup]

Key Takeaways

  • Chlamydia is a common yet serious bacterial infection that can affect pregnancy if left untreated. 
  • However, with early detection, proper treatment, and preventive care, both mothers and babies can avoid many of the potential risks. 
  • If you're pregnant or planning to conceive, discuss your sexual health and get screened regularly to protect yourself and your baby.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!
  1. About Chlamydia. (2024). Centers for Disease Control and Prevention. https://www.cdc.gov/chlamydia/about/index.html
  2. Chlamydia. (2023). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/4023-chlamydia
  3. Chlamydia. (2024, November 21). World Health Organization. https://www.who.int/news-room/fact-sheets/detail/chlamydia
  4. Chlamydia During Pregnancy. (2017, July 1). American Pregnancy Association. https://americanpregnancy.org/healthy-pregnancy/pregnancy-complications/chlamydia-during-pregnancy/
  5. Chlamydial infections. (2021, July 22). Centers for Disease Control and Prevention. https://www.cdc.gov/std/treatment-guidelines/chlamydia.htm
  6. Christie, J. (2023, January 31). 7 functional medicine labs to test for root cause of infertility in women. Rupa Health. https://www.rupahealth.com/post/7-functional-medicine-labs-to-test-for-root-cause-of-infertility-in-women
  7. Dental Dam. (2022, May 3). Cleveland Clinic. https://my.clevelandclinic.org/health/drugs/22887-dental-dam
  8. Duncan, B. (2001). Qualitative analysis of psychosocial impact of diagnosis of Chlamydia trachomatis: implications for screening. BMJ, 322(7280), 195–199. https://doi.org/10.1136/bmj.322.7280.195
  9. Dzakah, E. E., Zhao, J., Wang, L., et al. (2022). Chlamydia trachomatis Stimulation Enhances HIV-1 Susceptibility through the Modulation of a Member of the Macrophage Inflammatory Proteins. Journal of Investigative Dermatology, 142(5), 1338-1348.e6. https://doi.org/10.1016/j.jid.2021.09.020
  10. East, C. E., Biro, M. A., Fredericks, S., et al. (2019). Support during pregnancy for women at increased risk of low birthweight babies. Cochrane Database of Systematic Reviews, 4(4), CD000198. https://doi.org/10.1002/14651858.cd000198.pub3
  11. East, L., Jackson, D., Peters, K., et al. (2009). Disrupted sense of self: young women and sexually transmitted infections. Journal of Clinical Nursing, 19(13-14), 1995–2003. https://doi.org/10.1111/j.1365-2702.2009.03183.x
  12. LeFevre, M. L., & U.S. Preventive Services Task Force. (2014). Screening for Chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 161(12), 902–910. https://doi.org/10.7326/M14-1981
  13. Mårdh, P.-A. (2002). Influence of infection with Chlamydia trachomatis on pregnancy outcome, infant health and life-long sequelae in infected offspring. Best Practice & Research Clinical Obstetrics & Gynaecology, 16(6), 847–864. https://doi.org/10.1053/beog.2002.0329
  14. Marrazzo, J. M., Coffey, P., & Bingham, A. (2005). Sexual Practices, Risk Perception and Knowledge Of Sexually Transmitted Disease Risk Among Lesbian and Bisexual Women. Perspectives on Sexual and Reproductive Health, 37(1), 6–12. https://doi.org/10.1363/psrh.37.006.05
  15. Miller, K. E. (2004). Chlamydia trachomatis Exposure in Newborns. American Family Physician, 69(3), 727–732. https://www.aafp.org/pubs/afp/issues/2004/0201/p727a.html
  16. Mishori, R., McClaskey, E. L., & Winklerprins, V. J. (2012). Chlamydia Trachomatis Infections: Screening, Diagnosis, and Management. American Family Physician, 86(12), 1127–1132. https://www.aafp.org/pubs/afp/issues/2012/1215/p1127.html
  17. Mohseni, M., Sung, S., & Takov, V. (2023, August 8). Chlamydia. National Library of Medicine; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK537286/
  18. Neibling, K. (2023, March 3). A Functional Medicine Protocol for Reoccurring Pelvic Inflammatory Disease. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-protocol-to-reoccurring-pelvic-inflammatory-disease
  19. Niccolai, L. M. (2005). Condom effectiveness for prevention of Chlamydia trachomatis infection. Sexually Transmitted Infections, 81(4), 323–325. https://doi.org/10.1136/sti.2004.012799
  20. Patel, R. S., & Parmar, M. (2023, May 22). Doxycycline Hyclate. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK555888/
  21. Pitsouni, E., Iavazzo, C., Athanasiou, S., et al. (2007). Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials. International Journal of Antimicrobial Agents, 30(3), 213–221. https://doi.org/10.1016/j.ijantimicag.2007.04.015
  22. Rihl, M. (2006). Persistent infection of Chlamydia in reactive arthritis. Annals of the Rheumatic Diseases, 65(3), 281–284. https://doi.org/10.1136/ard.2005.044966
  23. Rours, G. I. J. G., Duijts, L., Moll, H. A., et al. (2011). Chlamydia trachomatis infection during pregnancy associated with preterm delivery: a population-based prospective cohort study. European Journal of Epidemiology, 26(6), 493–502. https://doi.org/10.1007/s10654-011-9586-1
  24. Screening Recommendations and Considerations Referenced in Treatment Guidelines and Original Sources. (2021). Centers for Disease Control and Prevention. https://www.cdc.gov/std/treatment-guidelines/screening-recommendations.htm
  25. Torrone, E., Papp, J., & Weinstock, H. (2014). Prevalence of Chlamydia trachomatis Genital Infection Among Persons Aged 14–39 Years — United States, 2007–2012. Morbidity and Mortality Weekly Report (MMWR), 63(38), 834–838. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6338a3.htm
Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Women's Health
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.

Hey practitioners! 👋 Join Dr. Robert Silverman for an insightful webinar, "Food Sensitivities, GLP-1, and Gut Health" on April 2nd at 2 PM EST / 11 AM PST. In this session, you'll gain insight into how GLP-1 may play a role in gut function, metabolism, and immune response, how food sensitivities may be linked to digestive discomfort, and practical strategies to help support gut health and overall well-being. Register now to secure your spot!